2-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-amine, 95%, 1g

2-Fluoro-5-methylphenylboronic acid, 97.00%, 1g

2-Chloro-5-nitrobenzenesulfonamide, 95.0%, 500g

1-(3-Hydroxyphenyl)-piperazine, 98.0%, 5g

3-{4-Oxo-5-[1-phenyl-meth-(Z)-ylidene]-2-thioxo-thiazolidin-3-yl}-benzoic acid, 95.0%, 500mg

1,4-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 1g

4'-BROMO-4-ETHOXY-2,3-DIFLUORO-1,1'-BIPHENYL, 97.0%, 1g

N-alpha-Boc-N-gamma-Fmoc-L-Diaminobutyric acid, 98.0%, 5g

Boc-3-amino-5-(fmoc-amino)-benzoic acid, 95%, 10g

tert-butyl methyl ether, min. 99.5%, for synthesis, 1 l, glass packaging

5-Formyl-5,6,7,8-tetrahydrofolic acid calcium salt, 97.0%, 10g

5-(5-Chloro-2-thienyl)-2-methylpyridine, 97.0%, 2g

2-(3-Fluorophenyl)pyridin-3-amine, 95+%, 100mg